| Hans-Günter Meyer-Thompson | Buprenorphin
Pharmacoeconomic Review Report: Buprenorphine extended-release injection (Sublocade): (Indivior Canada, Ltd.)
Pharmacoeconomic Review Report: Buprenorphine extended-release injection (Sublocade): (Indivior Canada, Ltd.)
Indication: For the management of moderate-to-severe opioid use disorder in adult patients who have been inducted and clinically stabilized on a transmucosal buprenorphine-containing product [Internet].
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2019 Jul.